Find a Clinical Trial
Filter
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-01)
Breast cancer, Locally advanced and metastatic breast cancer
All genders
Recruiting now
Cancer Center
BoppliTM blood pressure monitoring
Neonatal care
All genders
Recruiting now
Department of Pediatrics
Evaluation of BE1116 (4F-PCC) in patients with traumatic injury and confirmed or suspected acute major bleeding to improve survival
Trauma
All genders
Recruiting now
Department of Surgery, Division of Trauma
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
AbCLO Open Abdomen Study
Surgery, Trauma
All genders
Recruiting now
Department of Surgery
Breast Cancer Database
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (CAMBRIA-1)
All genders
Recruiting now
Cancer Center
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast cancer
All genders
Recruiting now
Cancer Center
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
ELGAN 3
Premature babies, Premature birth
All genders
Recruiting now
Department of Pediatrics